Shionogi & Co. Ltd
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.
Market Cap & Net Worth: Shionogi & Co. Ltd (SGIOF)
Shionogi & Co. Ltd (PINK:SGIOF) has a market capitalization of $13.11 Billion ($13.11 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #1370 globally and #1046 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shionogi & Co. Ltd's stock price $15.40 by its total outstanding shares 850976249 (850.98 Million).
Shionogi & Co. Ltd Market Cap History: 2015 to 2025
Shionogi & Co. Ltd's market capitalization history from 2015 to 2025. Data shows growth from $9.45 Billion to $13.11 Billion (4.13% CAGR).
Shionogi & Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shionogi & Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Shionogi & Co. Ltd's market cap is 0.03 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.08x
Shionogi & Co. Ltd's market cap is 0.08 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.38 Billion | $309.97 Billion | $66.69 Billion | 0.03x | 0.16x |
| 2017 | $11.86 Billion | $338.89 Billion | $83.88 Billion | 0.04x | 0.14x |
| 2018 | $12.30 Billion | $344.67 Billion | $108.87 Billion | 0.04x | 0.11x |
| 2019 | $14.22 Billion | $363.72 Billion | $132.76 Billion | 0.04x | 0.11x |
| 2020 | $13.35 Billion | $333.37 Billion | $122.19 Billion | 0.04x | 0.11x |
| 2021 | $17.80 Billion | $297.18 Billion | $111.86 Billion | 0.06x | 0.16x |
| 2022 | $12.72 Billion | $335.14 Billion | $114.19 Billion | 0.04x | 0.11x |
| 2023 | $12.98 Billion | $426.68 Billion | $184.97 Billion | 0.03x | 0.07x |
| 2024 | $10.56 Billion | $435.08 Billion | $162.03 Billion | 0.02x | 0.07x |
| 2025 | $13.11 Billion | $438.27 Billion | $170.44 Billion | 0.03x | 0.08x |
Competitor Companies of SGIOF by Market Capitalization
Companies near Shionogi & Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shionogi & Co. Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shionogi & Co. Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Shionogi & Co. Ltd's market cap moved from $9.45 Billion to $ 13.11 Billion, with a yearly change of 4.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $13.11 Billion | +24.09% |
| 2024 | $10.56 Billion | -18.62% |
| 2023 | $12.98 Billion | +2.04% |
| 2022 | $12.72 Billion | -28.56% |
| 2021 | $17.80 Billion | +33.37% |
| 2020 | $13.35 Billion | -6.16% |
| 2019 | $14.22 Billion | +15.64% |
| 2018 | $12.30 Billion | +3.69% |
| 2017 | $11.86 Billion | +14.32% |
| 2016 | $10.38 Billion | +9.83% |
| 2015 | $9.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shionogi & Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.11 Billion USD |
| MoneyControl | $13.11 Billion USD |
| MarketWatch | $13.11 Billion USD |
| marketcap.company | $13.11 Billion USD |
| Reuters | $13.11 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.